Rodolphe Elineau’s practice focuses on corporate and financial matters, including M&A and corporate governance.

Rodolphe advises both French and foreign companies on strategic and complex transactions. He also frequently advises listed companies on corporate governance matters and in connection with their general shareholders’ meetings, as well as on shareholder activism matters.

Rodolphe joined the firm in 2011 and became a partner in 2020.

Notable Experience

  • Roquette in its pending acquisition of IFF’s Pharma Solutions business.

  • Auchan Retail in its proposed €1.35 billion acquisition of Casino’s supermarkets and hypermarkets, in consortium with Groupement Les Mousquetaires.

  • Artémis in the acquisition of a majority stake in CAA.

  • Thales in its $3.6 billion acquisition of Imperva from Thoma Bravo.

  • Alimentation Couche Tard in the €3.1 billion acquisition of TotalEnergies’ retail network in Germany, the Netherlands, Belgium, and Luxembourg.

  • Giammaria Giuliani in the €3.7 billion take private of Rothschild & Co.

  • Veolia in its €12.9 billion acquisition of Suez and in the related divestments of certain Suez remedy assets.

  • Collibra on the re-domiciliation of its parent entity from Belgium to the Netherlands.

  • IGY Marinas in its $480 million acquisition by MarineMax.

  • Thales in the combination of its cellular IoT business with Telit.

  • General Mills in its sale of its European operations to Sodiaal.

  • BlackRock and Silver Point in the sale of the Pharma Solutions and Process Solutions businesses of Novasep to Bridgepoint/PharmaZell.

  • Attestor in its €2.9 billion acquisition of Europcar Mobility Group, in a consortium with Volkswagen AG and Pon Holdings BV.

  • IFF in the sale of its fruit and vegetable preparation business to Frulact.

  • Vale in the sale of its New Caledonia nickel assets to Prony Resources.

  • Worldline in its €7.8 billion acquisition of Ingenico to create a new world-class leader in payment services.

  • Capgemini in its €5 billion acquisition of Altran Technologies.

  • Thales in its €5.4 billion acquisition of Gemalto and in the divestment of its general purpose hardware security modules business to Entrust Datacard Corporation.

  • Total in various transactions, including its €950 million acquisition of Saft Groupe, its €2.5 billion acquisition of Direct Énergie and the sale to the Borealis Group of its fertilizer subsidiaries GPN and Rosier.

  • General Motors in its €2 billion divestment of Opel/Vauxhall and GM Financial’s European operations to PSA Group.

  • SK Global Chemical in its €335 million acquisition of Arkema’s Functional Polyolefin business.

  • Tikehau Capital in connection with its €610 million rights offering.

  • Safran in its €2.4 billion divestment of its identity and security activities to Advent International.

  • Goldman Sachs, as financial advisor to the board of directors of Safran, in its € 7.5 billion combination with Zodiac Aerospace.

  • Capgemini in repurchase of €574.4 million existing notes and a €1.1 billion issuance.

  • Bridgepoint in the sale of portfolio company Médipôle Partenaires to Elsan, creating the leader in French health care.

  • Gameloft in connection with Vivendi’s €700 million hostile tender offer.

  • Vallourec in the reorganization of its Brazilian activities and its reserved capital increases in favor of NSSMC and Bpifrance.

  • Lafarge in its €40 billion merger with Holcim to create LafargeHolcim, the world’s largest construction materials company.

  • Lafarge in several other M&A transactions, including the divestment by competitive process of €6.5 billion of assets as part of regulatory approval requirements for its merger with Holcim.

  • Medica in its merger with Korian to create the European leader of elderly care sector.

  • Alcatel Lucent in connection with a major partnership with Qualcomm to develop small cells.

  • Sanofi in connection with the divestiture of its direct and indirect stake in the Yves Rocher Group.

  • Emerging Capital Partners (ECP) in connection with the development of its subsidiary Oragroup.

  • Groupama in the sale of Silic to Icade and the issuance of €300 million preferred shares by Gan Eurocourtage.

See More